Every year, millions of women face a preventable threat: cervical cancer. In fact, certain high-risk types of the Cervical cancer virus (HPV) cause about 70 % of cases globally, as per a
study published in the NIH. Thanks to medical advances, a vaccine now offers powerful protection for girls and women, but it is no magic wand. For the greatest benefit, the vaccine must be given early, and it must be paired with ongoing screening. One
large Swedish study found that women vaccinated before age 17 had nearly a 90 % reduction in cervical cancer over 11 years.
While this is deeply hopeful, it remains essential to understand how the vaccine works, what side effects can appear, and who should approach it with caution. Here’s everything we need to know about the preventive cervical cancer vaccine.
How the vaccine protects
The cervical-cancer vaccine targets infection by specific high-risk HPV types, especially types 16 and 18, which together cause about 70 % of cervical cancers.
When given before someone becomes sexually active (and thus before exposure to those HPV types), the vaccine blocks those infections and the early cell changes that could lead to cancer. A
systematic review published in 2021 found vaccines to be “remarkably high” in effectiveness among young women before exposure.
The HPV vaccine teaches the body's immune system to fight the Human Papillomavirus, which can affect the cervix, vagina, and genital area. Most cervical cancers are caused by two types of HPV, called HPV 16 and HPV 18. The vaccine does not include a live virus, so it can't cause infection. When given before someone is exposed to the virus, especially before they start having sex, it can prevent more than 90% of cervical cancers linked to HPV. India has started using a vaccine made locally called Cervavac, which is more affordable and easier to get for teenagers across the country.
Dr Meenu Walia, Chairman - Medical Oncology (Breast, Gynaecology, Thoracic), Max Super Speciality Hospital, Vaishali
: a Swedish cohort of almost 1.7 million women found vaccination cut cervical cancer diagnoses by 63 % overall, and further reduction to nearly 90 % when vaccination occurred early.
The vaccine doesn’t treat an existing HPV infection, but when administered early it acts like a protective shield, giving girls and young women a strong head-start.
What the evidence says on side-effects
Like any vaccine, the cervical-cancer (HPV) vaccine brings some side-effects, but the vast majority are mild and temporary. According to the
Centers for Disease Control and Prevention (CDC) review: pain, swelling or redness at the injection site are the most common. Approximately 97 % of reported events from December 2014 to December 2017 were non-serious.
Some other commonly observed effects include:- Headache, feeling tired or faint (dizziness)
- Nausea, fever, muscle or joint pain
- Rarely, fainting (syncope) which is why sitting or lying down immediately after the shot is often recommended.
- Importantly, long-term safety monitoring (over 15+ years) shows no new or unexpected risks for these vaccines.
So while vigilance is always warranted, the safety record is strong.
Who should take it, and when
Guidance from
WHO and major health bodies recommends girls aged 9–14 as the primary target for two doses.
Women up to age 45 may still benefit, especially if they have not been previously vaccinated or exposed.
The protection is greatest when the vaccine is given early. For example, in Sweden the strongest reductions in cervical cancer occurred in those vaccinated before age 17.
Furthermore: The vaccine works best before HPV exposure. If an individual already has the virus or precancerous lesions, the vaccine will not "reverse" those.
Preventative cervical cancer vaccine is another essential measure in helping to prevent the Human Papillomavirus (HPV) that causes most incidences of cervical cancer in women and girls. Ideally, it is to be administered to girls aged 9-14 years of age, before the sexual activity sets in, though women even up to 26 years are good beneficiaries. The vaccine provides long-lasting protection- up to several years- against HPV high-risk strains which causes cervical and other related cancers. Side effects are mild and not lasting, including pain or reddening of the injection area, low-grade fever, or even sleepiness.
Dr Amrita Razdan Kaul, Sr. Consultant- Obstetrics & Gynaecology, Asian Hospital
It complements but does not replace cervical-screening programmes. Even vaccinated individuals must continue routine Pap smears or HPV tests.
In short: vaccinate early, but don’t assume “once and done,” screening remains crucial.
Who should think twice or avoid it
While the vaccine is safe for most, there are specific situations where caution or avoidance is advised:
- Severe allergic reaction history: If someone has had a serious allergic reaction (anaphylaxis) to a previous dose or to any component (like yeast, for certain formulations) they should not get it.
- Pregnancy: Most guidelines suggest deferring the vaccine if pregnant, since its safety in pregnant women has not been fully established.
- Acute illness at the time: If someone is moderately or severely ill, vaccination may be postponed until recovery.
- Exposure history: Individuals already fully exposed to many HPV types (older age, many partners) may get less benefit, so a healthcare provider may guide the decision.
The vaccine is generally very safe, and side effects, including pain or redness at the injection site, mild fever, headache, or fatigue, usually resolve within a day or two. Contraindications are mainly established for patients with severe allergic reactions to any component of this vaccine, including those who are pregnant, until advised otherwise by their doctor. They must understand that together, vaccination and regular cervical screening provide the best preventive defense against a completely preventable disease.
Dr Ankit Jain, senior consultant, medical oncology, Indraprastha Apollo Hospitals
These are not reasons to fear the vaccine, they are just tailored considerations to make the decision safely.
The cervical-cancer vaccine is a profound tool in women's health, one of the few vaccines that actually prevents a solid tumour. When given early and coupled with screening, it can drastically lower risk. Side effects are overwhelmingly mild; long-term safety data are robust. Yet it’s not for everyone at every moment, timing and context matter. The decision to vaccinate is best made in consultation with a trusted healthcare provider who understands individual risk, exposure history, and local cancer-screening context.
Disclaimer: This article is for informational purposes only. It does not substitute for medical advice. Consult a qualified healthcare professional to determine whether the HPV-cervical-cancer vaccine is appropriate based on your personal health, history and local guidelines.
Start a Conversation
Post comment